Symbio Pharmaceuticals Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Symbio Pharmaceuticals Ltd with three other
companies in this sector in Japan:
Trans Genic Inc
sales of 2.29 billion Japanese Yen [US$20.45 million]
of which 48%
was CRO Business),
Medical Data Vision Co Ltd
(2.63 billion Japanese Yen [US$23.51 million]
of which 55%
was Data network service), and
Medinet Co., Ltd.
(1.91 billion Japanese Yen [US$17.05 million]
of which 98%
was cell processing).
Symbio Pharmaceuticals Ltd reported sales of ¥2.37 billion (US$21.15 million)
December of 2016.
increase of 22.5%
versus 2015, when the company's sales were ¥1.93 billion.